E
Eric J. Topol
Researcher at Scripps Health
Publications - 1406
Citations - 162373
Eric J. Topol is an academic researcher from Scripps Health. The author has contributed to research in topics: Myocardial infarction & Angioplasty. The author has an hindex of 193, co-authored 1373 publications receiving 151025 citations. Previous affiliations of Eric J. Topol include Loyola University Chicago & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
Advances in thrombolytic therapy for acute myocardial infarction.
TL;DR: This review will focus primarily on the recent advances in thrombolytic therapy, with particular attention to efficacy, safety, and comparative aspects of the various agents currently or soon to be available.
Journal ArticleDOI
Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment
Debabrata Mukherjee,Eric J. Topol,David J. Moliterno,Danielle M. Brennan,Khaled M. Ziada,Leslie Cho,Steven R. Steinhubl +6 more
TL;DR: Longer term clopidogrel treatment provides added protection against thrombotic events throughout the arterial vasculature, not limited to the coronary arteries, and may be especially effective for patients with more diffuse atherosclerosis such as ECVD.
Journal Article
Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization : Insights from the CREDO trial
Sorin J. Brener,Steven R. Steinhubl,Peter B. Berger,Danielle M. Brennan,Eric J. Topol,Credo Investigators +5 more
TL;DR: Overall, patients with TVR experienced an ischemic event much more often that was not related to the PCI vessel, suggesting that the benefit of antiplatelet therapy after coronary revascularization is indexed to the patient's underlying atherothrombotic process, rather than the artery that underwent intervention.
Longitudinal Genome-Wide Association of Cardiovascular Disease Risk Factors in the Bogalusa Heart Study
Leena Peltonen,Erin N. Smith,Wei Chen,Mika Kähönen,Johannes Kettunen,Terho Lehtimäki,Olli T. Raitakari,Rany M. Salem,Nicholas J. Schork,Marian Shaw,Sathanur R. Srinivasan,Eric J. Topol,Jorma Viikari,Gerald S. Berenson,Sarah S. Murray +14 more
TL;DR: This is the first GWA study to evaluate the role of common genetic variants in the development of CVD risk factors in children as they advance through adulthood and highlights the utility of using longitudinal studies to identify genetic predictors of adult traits in children.